Page last updated: 2024-08-18

4-butyrolactone and mitoxantrone

4-butyrolactone has been researched along with mitoxantrone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Álvarez, AI; Espín, JC; García-Villalba, R; Merino, G; Miguel, V; Otero, JA; Tomás-Barberán, F1
Álvarez, AI; Espín, JC; García-Villalba, R; González-Lobato, L; Merino, G; Miguel, V; Otero, JA; Prieto, JG1
Arenas, C; Granados-Soler, JL; Peña, L; Pérez-Alenza, MD1

Other Studies

3 other study(ies) available for 4-butyrolactone and mitoxantrone

ArticleYear
Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in Abcg2 knockout mice.
    Drug metabolism and disposition: the biological fate of chemicals, 2014, Volume: 42, Issue:5

    Topics: 4-Butyrolactone; Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Diketopiperazines; Dogs; Female; Heterocyclic Compounds, 4 or More Rings; Lignans; Madin Darby Canine Kidney Cells; Mice; Mice, Knockout; Milk; Mitoxantrone; Neoplasm Proteins; Substrate Specificity

2014
Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.
    Animal : an international journal of animal bioscience, 2016, Volume: 10, Issue:2

    Topics: 4-Butyrolactone; Animals; ATP-Binding Cassette Transporters; Biological Transport; Butylene Glycols; Cattle; Dogs; Female; Lactation; Lignans; Madin Darby Canine Kidney Cells; Milk; Mitoxantrone; Polymorphism, Single Nucleotide; Riboflavin; Uric Acid

2016
Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    The Veterinary record, 2016, Jul-30, Volume: 179, Issue:5

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Case-Control Studies; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Mammary Neoplasms, Animal; Mitoxantrone; Prospective Studies; Sulfones; Treatment Outcome

2016